В контролирани клинични изпитвания фаза ІІ и ІІІ са включени над 4 874 пациенти. р
ra The fondaparinux clinical program in treatment of Venous Thromboembolism was designed to demonstrate the efficacy of fondaparinux for the treatment of deep vein thrombosis (DVT) and